

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 4.81176631 |
| 2 | lysine catabolic process (GO:0006554) | 4.81176631 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.55072228 |
| 4 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.41147782 |
| 5 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.29796417 |
| 6 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.21314555 |
| 7 | urea cycle (GO:0000050) | 4.18744063 |
| 8 | urea metabolic process (GO:0019627) | 4.18744063 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.16048810 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.16048810 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.05743746 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.05743746 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.97768615 |
| 14 | negative regulation of fibrinolysis (GO:0051918) | 3.94874726 |
| 15 | embryonic process involved in female pregnancy (GO:0060136) | 3.92523784 |
| 16 | negative regulation of sodium ion transport (GO:0010766) | 3.91397291 |
| 17 | cysteine metabolic process (GO:0006534) | 3.78314501 |
| 18 | kynurenine metabolic process (GO:0070189) | 3.67185352 |
| 19 | glutamate metabolic process (GO:0006536) | 3.63990242 |
| 20 | regulation of cholesterol homeostasis (GO:2000188) | 3.63671290 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 3.61329670 |
| 22 | regulation of fatty acid oxidation (GO:0046320) | 3.55673732 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.51816422 |
| 24 | response to laminar fluid shear stress (GO:0034616) | 3.50969013 |
| 25 | protein localization to endosome (GO:0036010) | 3.50180514 |
| 26 | positive regulation of lipid catabolic process (GO:0050996) | 3.50085374 |
| 27 | hypotonic response (GO:0006971) | 3.48416851 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 3.48064469 |
| 29 | protein carboxylation (GO:0018214) | 3.44906734 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44906734 |
| 31 | high-density lipoprotein particle remodeling (GO:0034375) | 3.43556610 |
| 32 | one-carbon metabolic process (GO:0006730) | 3.41823044 |
| 33 | aspartate family amino acid catabolic process (GO:0009068) | 3.40396367 |
| 34 | aromatic amino acid family catabolic process (GO:0009074) | 3.39690871 |
| 35 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39451815 |
| 36 | positive regulation of fatty acid oxidation (GO:0046321) | 3.38979483 |
| 37 | fatty acid transmembrane transport (GO:1902001) | 3.33337726 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.33178473 |
| 39 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.32862436 |
| 40 | carnitine shuttle (GO:0006853) | 3.31412870 |
| 41 | regulation of fibrinolysis (GO:0051917) | 3.29674633 |
| 42 | negative regulation of sterol transport (GO:0032372) | 3.29639647 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 3.29639647 |
| 44 | oxaloacetate metabolic process (GO:0006107) | 3.28261920 |
| 45 | NIK/NF-kappaB signaling (GO:0038061) | 3.27163075 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 3.24744009 |
| 47 | negative regulation of cell size (GO:0045792) | 3.23074355 |
| 48 | response to peptidoglycan (GO:0032494) | 3.22618473 |
| 49 | glyoxylate metabolic process (GO:0046487) | 3.22043680 |
| 50 | peptidyl-lysine dimethylation (GO:0018027) | 3.19025605 |
| 51 | germinal center formation (GO:0002467) | 3.18958723 |
| 52 | regulation of protein activation cascade (GO:2000257) | 3.17905207 |
| 53 | ethanol oxidation (GO:0006069) | 3.15061824 |
| 54 | regulation of vitamin metabolic process (GO:0030656) | 3.14432322 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 3.13296163 |
| 56 | complement activation, alternative pathway (GO:0006957) | 3.09106384 |
| 57 | valine metabolic process (GO:0006573) | 3.07682122 |
| 58 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.07517653 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05670988 |
| 60 | glycine metabolic process (GO:0006544) | 3.02617635 |
| 61 | reverse cholesterol transport (GO:0043691) | 3.02544310 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 3.02186202 |
| 63 | tolerance induction (GO:0002507) | 3.02049363 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 3.01427032 |
| 65 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.99743335 |
| 66 | acylglycerol homeostasis (GO:0055090) | 2.97643306 |
| 67 | triglyceride homeostasis (GO:0070328) | 2.97643306 |
| 68 | 4-hydroxyproline metabolic process (GO:0019471) | 2.96040176 |
| 69 | serine family amino acid catabolic process (GO:0009071) | 2.95550242 |
| 70 | mannose metabolic process (GO:0006013) | 2.95077987 |
| 71 | pinocytosis (GO:0006907) | 2.94570024 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93392465 |
| 73 | regulation of complement activation (GO:0030449) | 2.93234562 |
| 74 | plasma lipoprotein particle clearance (GO:0034381) | 2.91716894 |
| 75 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88802389 |
| 76 | negative regulation of lipase activity (GO:0060192) | 2.87180364 |
| 77 | alpha-amino acid catabolic process (GO:1901606) | 2.86757690 |
| 78 | modulation by symbiont of host cellular process (GO:0044068) | 2.86112375 |
| 79 | regulation of lipid catabolic process (GO:0050994) | 2.85243770 |
| 80 | regulation of translational fidelity (GO:0006450) | 2.82385648 |
| 81 | negative regulation of lipid transport (GO:0032369) | 2.81238588 |
| 82 | acylglycerol catabolic process (GO:0046464) | 2.79852300 |
| 83 | neutral lipid catabolic process (GO:0046461) | 2.79852300 |
| 84 | homocysteine metabolic process (GO:0050667) | 2.78771027 |
| 85 | ketone body metabolic process (GO:1902224) | 2.78467803 |
| 86 | negative regulation of fatty acid transport (GO:2000192) | 2.77912449 |
| 87 | indole-containing compound catabolic process (GO:0042436) | 2.77738168 |
| 88 | indolalkylamine catabolic process (GO:0046218) | 2.77738168 |
| 89 | tryptophan catabolic process (GO:0006569) | 2.77738168 |
| 90 | acetyl-CoA metabolic process (GO:0006084) | 2.77225759 |
| 91 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.76693937 |
| 92 | epoxygenase P450 pathway (GO:0019373) | 2.76249094 |
| 93 | plasma lipoprotein particle remodeling (GO:0034369) | 2.74206650 |
| 94 | protein-lipid complex remodeling (GO:0034368) | 2.74206650 |
| 95 | macromolecular complex remodeling (GO:0034367) | 2.74206650 |
| 96 | bile acid metabolic process (GO:0008206) | 2.72750797 |
| 97 | regulation of translational termination (GO:0006449) | 2.72202004 |
| 98 | protein-lipid complex assembly (GO:0065005) | 2.71886136 |
| 99 | imidazole-containing compound metabolic process (GO:0052803) | 2.71885421 |
| 100 | regulation of early endosome to late endosome transport (GO:2000641) | 2.71469245 |
| 101 | positive regulation of extracellular matrix organization (GO:1903055) | 2.69202901 |
| 102 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.67198019 |
| 103 | phospholipid homeostasis (GO:0055091) | 2.67062846 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 2.65868096 |
| 105 | low-density lipoprotein particle clearance (GO:0034383) | 2.65843971 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 2.65015970 |
| 107 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.64391510 |
| 108 | negative regulation of interleukin-8 production (GO:0032717) | 2.64312750 |
| 109 | short-chain fatty acid metabolic process (GO:0046459) | 2.63464995 |
| 110 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.62759126 |
| 111 | stress fiber assembly (GO:0043149) | 2.62522815 |
| 112 | skin morphogenesis (GO:0043589) | 2.61555407 |
| 113 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.61412584 |
| 114 | drug catabolic process (GO:0042737) | 2.61314482 |
| 115 | locomotory exploration behavior (GO:0035641) | 2.61006678 |
| 116 | tryptophan metabolic process (GO:0006568) | 2.60972117 |
| 117 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.60761336 |
| 118 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.60641772 |
| 119 | tricarboxylic acid metabolic process (GO:0072350) | 2.60279548 |
| 120 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.60090786 |
| 121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59123053 |
| 122 | serine family amino acid metabolic process (GO:0009069) | 2.58816478 |
| 123 | alanine transport (GO:0032328) | 2.58798363 |
| 124 | carnitine transmembrane transport (GO:1902603) | 2.58772445 |
| 125 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.58124683 |
| 126 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58090313 |
| 127 | dicarboxylic acid catabolic process (GO:0043649) | 2.56915156 |
| 128 | negative regulation of cell killing (GO:0031342) | 2.55128877 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55128877 |
| 130 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.52720668 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.52256342 |
| 132 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51744643 |
| 133 | cellular extravasation (GO:0045123) | 2.51230728 |
| 134 | regulation of integrin activation (GO:0033623) | 2.51039882 |
| 135 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.50718690 |
| 136 | necroptotic process (GO:0070266) | 2.48204060 |
| 137 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.46751743 |
| 138 | activation of MAPKKK activity (GO:0000185) | 2.45266716 |
| 139 | modulation by virus of host process (GO:0019054) | 2.44706731 |
| 140 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43056686 |
| 141 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.42416853 |
| 142 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.41463916 |
| 143 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.41230653 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.40775369 |
| 145 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.40204861 |
| 146 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.40046216 |
| 147 | establishment of endothelial barrier (GO:0061028) | 2.38954985 |
| 148 | positive thymic T cell selection (GO:0045059) | 2.38709182 |
| 149 | negative regulation of interleukin-12 production (GO:0032695) | 2.34516210 |
| 150 | thymic T cell selection (GO:0045061) | 2.33012748 |
| 151 | endothelial cell chemotaxis (GO:0035767) | 2.29890842 |
| 152 | regulation of anoikis (GO:2000209) | 2.29261212 |
| 153 | regulation of extracellular matrix disassembly (GO:0010715) | 2.28671544 |
| 154 | cell-substrate junction assembly (GO:0007044) | 2.28220500 |
| 155 | glycosphingolipid catabolic process (GO:0046479) | 2.27836544 |
| 156 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.25888528 |
| 157 | negative regulation of anoikis (GO:2000811) | 2.25587116 |
| 158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.24021394 |
| 159 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.23422508 |
| 160 | activation of JUN kinase activity (GO:0007257) | 2.23373975 |
| 161 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.22628790 |
| 162 | regulation of gamma-delta T cell activation (GO:0046643) | 2.22479712 |
| 163 | positive regulation of receptor recycling (GO:0001921) | 2.22352921 |
| 164 | endocytic recycling (GO:0032456) | 2.22343526 |
| 165 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.22242223 |
| 166 | decidualization (GO:0046697) | 2.22201175 |
| 167 | hemidesmosome assembly (GO:0031581) | 2.19996763 |
| 168 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.19459754 |
| 169 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.19115244 |
| 170 | cell adhesion mediated by integrin (GO:0033627) | 2.18990076 |
| 171 | myeloid dendritic cell activation (GO:0001773) | 2.15953852 |
| 172 | cellular response to arsenic-containing substance (GO:0071243) | 2.15775928 |
| 173 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.15219185 |
| 174 | mRNA transcription (GO:0009299) | 2.14220617 |
| 175 | activation of Rac GTPase activity (GO:0032863) | 2.13860207 |
| 176 | regulation of necroptotic process (GO:0060544) | 2.13587825 |
| 177 | T cell selection (GO:0045058) | 2.12197491 |
| 178 | negative regulation of viral release from host cell (GO:1902187) | 2.11752847 |
| 179 | response to fluid shear stress (GO:0034405) | 2.11450026 |
| 180 | COPI coating of Golgi vesicle (GO:0048205) | 2.11350853 |
| 181 | Golgi transport vesicle coating (GO:0048200) | 2.11350853 |
| 182 | T-helper 1 type immune response (GO:0042088) | 2.09779351 |
| 183 | macrophage activation involved in immune response (GO:0002281) | 2.09686983 |
| 184 | glycolipid catabolic process (GO:0019377) | 2.09684539 |
| 185 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.09328802 |
| 186 | modulation by symbiont of host defense response (GO:0052031) | 2.08740717 |
| 187 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.08740717 |
| 188 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.08740717 |
| 189 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.08740717 |
| 190 | modulation by symbiont of host immune response (GO:0052553) | 2.08740717 |
| 191 | positive regulation by symbiont of host defense response (GO:0052509) | 2.08740717 |
| 192 | focal adhesion assembly (GO:0048041) | 2.08634353 |
| 193 | cell-substrate adherens junction assembly (GO:0007045) | 2.08634353 |
| 194 | TRIF-dependent toll-like receptor signaling pathway (GO:0035666) | 2.07864822 |
| 195 | programmed necrotic cell death (GO:0097300) | 2.07683994 |
| 196 | barbed-end actin filament capping (GO:0051016) | 2.07543592 |
| 197 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.07390662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.85883110 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.67859327 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.23179316 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.18916455 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.65750220 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.63031156 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.48922308 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.14587444 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77546454 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.61125352 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.60855206 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.56695699 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.53673514 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.42960226 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.35881092 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35547681 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29500981 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23004230 |
| 19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.21971373 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.21789374 |
| 21 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17353684 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13573007 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.09790453 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02467122 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.00850784 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.00275759 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.96928136 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96700145 |
| 29 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89898791 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.89796698 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88034792 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.78153043 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77851918 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74505878 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.73067210 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.71805378 |
| 37 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68544292 |
| 38 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.67525233 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66179953 |
| 40 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.65768063 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65105276 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.64947375 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.64805708 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.64218831 |
| 45 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62888062 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61809020 |
| 47 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.59095571 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57091993 |
| 49 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.56422934 |
| 50 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.54595494 |
| 51 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.54213126 |
| 52 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.54001534 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.53616699 |
| 54 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53430180 |
| 55 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.50901419 |
| 56 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48572854 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48542617 |
| 58 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.48340376 |
| 59 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46287263 |
| 60 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.46019522 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.45933609 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45633556 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45377682 |
| 64 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43947799 |
| 65 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.43426720 |
| 66 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.42264063 |
| 67 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.41338320 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.39723753 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.39723753 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38912993 |
| 71 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37610070 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37276388 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35953621 |
| 74 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35899364 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35220964 |
| 76 | GATA1_22025678_ChIP-Seq_K562_Human | 1.31095829 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30224113 |
| 78 | * MAF_26560356_Chip-Seq_TH2_Human | 1.29811881 |
| 79 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.25868436 |
| 80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25166893 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25075605 |
| 82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24207547 |
| 83 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24001270 |
| 84 | * MYB_26560356_Chip-Seq_TH1_Human | 1.23515664 |
| 85 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22390258 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22215335 |
| 87 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21781072 |
| 88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.21680076 |
| 89 | * MYB_26560356_Chip-Seq_TH2_Human | 1.19047286 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15206632 |
| 91 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14911236 |
| 92 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14724833 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13849776 |
| 94 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13517192 |
| 95 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13384867 |
| 96 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.12947653 |
| 97 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12338969 |
| 98 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12279902 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11570020 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09992601 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09249237 |
| 102 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.09201783 |
| 103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09090780 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08424492 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08359603 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07984006 |
| 107 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07130259 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.06529596 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06466847 |
| 110 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.05473219 |
| 111 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05264857 |
| 112 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05237307 |
| 113 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.04882318 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.04108819 |
| 115 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03455092 |
| 116 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.01427365 |
| 117 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00834311 |
| 118 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99924828 |
| 119 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99890113 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99580752 |
| 121 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98633435 |
| 122 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98497897 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.98482901 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97157381 |
| 125 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96784287 |
| 126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95997755 |
| 127 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.95818099 |
| 128 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95769752 |
| 129 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95055555 |
| 130 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94469067 |
| 131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94255599 |
| 132 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94112398 |
| 133 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.93695381 |
| 134 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92250059 |
| 135 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.92133137 |
| 136 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.92133137 |
| 137 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91100779 |
| 138 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90681035 |
| 139 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90282848 |
| 140 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.89660615 |
| 141 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86230367 |
| 142 | MAF_26560356_Chip-Seq_TH1_Human | 0.85878895 |
| 143 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84634102 |
| 144 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83920215 |
| 145 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83403586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.57778270 |
| 2 | MP0005360_urolithiasis | 4.77226423 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.21418758 |
| 4 | MP0005365_abnormal_bile_salt | 4.01560439 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.99696830 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.60256933 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.00757178 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.94106584 |
| 9 | MP0003436_decreased_susceptibility_to | 2.85353937 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.84865946 |
| 11 | MP0004859_abnormal_synaptic_plasticity | 2.75008687 |
| 12 | MP0003252_abnormal_bile_duct | 2.44499022 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.34955480 |
| 14 | MP0004947_skin_inflammation | 2.32876850 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.30134346 |
| 16 | MP0002822_catalepsy | 2.20019975 |
| 17 | MP0005083_abnormal_biliary_tract | 2.17833856 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.12628955 |
| 19 | MP0005451_abnormal_body_composition | 2.04096434 |
| 20 | MP0003566_abnormal_cell_adhesion | 2.02413910 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.97076531 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.88021817 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 1.85765661 |
| 24 | MP0004130_abnormal_muscle_cell | 1.85337392 |
| 25 | MP0009278_abnormal_bone_marrow | 1.84096042 |
| 26 | MP0005000_abnormal_immune_tolerance | 1.82812862 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.82676664 |
| 28 | MP0000609_abnormal_liver_physiology | 1.81157798 |
| 29 | MP0008961_abnormal_basal_metabolism | 1.80779205 |
| 30 | MP0005409_darkened_coat_color | 1.79015179 |
| 31 | MP0003724_increased_susceptibility_to | 1.75351305 |
| 32 | MP0009840_abnormal_foam_cell | 1.71006382 |
| 33 | MP0008260_abnormal_autophagy | 1.70360891 |
| 34 | MP0001873_stomach_inflammation | 1.70308113 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.69418628 |
| 36 | MP0000685_abnormal_immune_system | 1.67627807 |
| 37 | MP0001666_abnormal_nutrient_absorption | 1.66344256 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.65559989 |
| 39 | MP0001851_eye_inflammation | 1.63508327 |
| 40 | MP0002118_abnormal_lipid_homeostasis | 1.63286585 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.61418748 |
| 42 | MP0002419_abnormal_innate_immunity | 1.61404253 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.61173184 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.58996503 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.56789093 |
| 46 | MP0005332_abnormal_amino_acid | 1.56615342 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.47311691 |
| 48 | MP0005025_abnormal_response_to | 1.46863781 |
| 49 | MP0001790_abnormal_immune_system | 1.46787382 |
| 50 | MP0005387_immune_system_phenotype | 1.46787382 |
| 51 | MP0000858_altered_metastatic_potential | 1.45169216 |
| 52 | MP0001800_abnormal_humoral_immune | 1.44853069 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.44604890 |
| 54 | MP0002452_abnormal_antigen_presenting | 1.42369798 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.40464512 |
| 56 | MP0003828_pulmonary_edema | 1.39450929 |
| 57 | MP0002723_abnormal_immune_serum | 1.38935817 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.38019086 |
| 59 | MP0002009_preneoplasia | 1.36237516 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.35452628 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.34425845 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 1.34223052 |
| 63 | MP0006082_CNS_inflammation | 1.33262759 |
| 64 | MP0002837_dystrophic_cardiac_calcinosis | 1.32060423 |
| 65 | MP0002420_abnormal_adaptive_immunity | 1.30234316 |
| 66 | MP0001853_heart_inflammation | 1.28391979 |
| 67 | MP0001819_abnormal_immune_cell | 1.27953507 |
| 68 | MP0003448_altered_tumor_morphology | 1.25381896 |
| 69 | MP0000604_amyloidosis | 1.23715191 |
| 70 | MP0002933_joint_inflammation | 1.21114511 |
| 71 | MP0003045_fibrosis | 1.21108493 |
| 72 | MP0005076_abnormal_cell_differentiation | 1.19725736 |
| 73 | MP0000598_abnormal_liver_morphology | 1.19028812 |
| 74 | MP0009785_altered_susceptibility_to | 1.17808146 |
| 75 | MP0002405_respiratory_system_inflammati | 1.16859593 |
| 76 | MP0002398_abnormal_bone_marrow | 1.16565396 |
| 77 | MP0003868_abnormal_feces_composition | 1.16144628 |
| 78 | MP0002060_abnormal_skin_morphology | 1.15325743 |
| 79 | MP0005187_abnormal_penis_morphology | 1.13901589 |
| 80 | MP0001216_abnormal_epidermal_layer | 1.12166927 |
| 81 | MP0010368_abnormal_lymphatic_system | 1.11895114 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11728642 |
| 83 | MP0006054_spinal_hemorrhage | 1.11632422 |
| 84 | MP0003329_amyloid_beta_deposits | 1.11495600 |
| 85 | MP0001845_abnormal_inflammatory_respons | 1.10709202 |
| 86 | MP0010307_abnormal_tumor_latency | 1.10467938 |
| 87 | MP0002254_reproductive_system_inflammat | 1.10045337 |
| 88 | MP0005310_abnormal_salivary_gland | 1.08877571 |
| 89 | MP0003303_peritoneal_inflammation | 1.08198863 |
| 90 | MP0001849_ear_inflammation | 1.06329229 |
| 91 | MP0000716_abnormal_immune_system | 1.05835761 |
| 92 | MP0003635_abnormal_synaptic_transmissio | 1.05162038 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 1.04929895 |
| 94 | MP0005375_adipose_tissue_phenotype | 1.04111533 |
| 95 | MP0002166_altered_tumor_susceptibility | 1.04040473 |
| 96 | MP0002396_abnormal_hematopoietic_system | 1.03116809 |
| 97 | MP0008004_abnormal_stomach_pH | 1.02413132 |
| 98 | MP0004264_abnormal_extraembryonic_tissu | 1.02215648 |
| 99 | MP0002796_impaired_skin_barrier | 1.00439234 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.99952176 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.99062504 |
| 102 | MP0000490_abnormal_crypts_of | 0.98990541 |
| 103 | MP0008438_abnormal_cutaneous_collagen | 0.98614850 |
| 104 | MP0002909_abnormal_adrenal_gland | 0.97722292 |
| 105 | MP0003866_abnormal_defecation | 0.96983238 |
| 106 | MP0003075_altered_response_to | 0.96513567 |
| 107 | MP0002006_tumorigenesis | 0.96198319 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.95341231 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.95341231 |
| 110 | MP0002429_abnormal_blood_cell | 0.93079004 |
| 111 | MP0005535_abnormal_body_temperature | 0.92546448 |
| 112 | MP0008872_abnormal_physiological_respon | 0.91259498 |
| 113 | MP0000249_abnormal_blood_vessel | 0.90737049 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.89788055 |
| 115 | MP0002971_abnormal_brown_adipose | 0.89705356 |
| 116 | MP0008469_abnormal_protein_level | 0.88997527 |
| 117 | MP0005164_abnormal_response_to | 0.88696699 |
| 118 | MP0005621_abnormal_cell_physiology | 0.88566894 |
| 119 | MP0004510_myositis | 0.87821497 |
| 120 | MP0009931_abnormal_skin_appearance | 0.87744299 |
| 121 | MP0000703_abnormal_thymus_morphology | 0.87445158 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.87348382 |
| 123 | MP0002722_abnormal_immune_system | 0.86443059 |
| 124 | MP0005166_decreased_susceptibility_to | 0.85410041 |
| 125 | MP0003950_abnormal_plasma_membrane | 0.84267849 |
| 126 | MP0009672_abnormal_birth_weight | 0.84160328 |
| 127 | MP0003279_aneurysm | 0.83624246 |
| 128 | MP0001915_intracranial_hemorrhage | 0.83551592 |
| 129 | MP0003195_calcinosis | 0.83367239 |
| 130 | MP0003795_abnormal_bone_structure | 0.83186839 |
| 131 | MP0008874_decreased_physiological_sensi | 0.82369582 |
| 132 | MP0001944_abnormal_pancreas_morphology | 0.82020500 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.81979222 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.81849089 |
| 135 | MP0001958_emphysema | 0.80815537 |
| 136 | MP0005167_abnormal_blood-brain_barrier | 0.79817006 |
| 137 | MP0005390_skeleton_phenotype | 0.78685410 |
| 138 | MP0005165_increased_susceptibility_to | 0.78505646 |
| 139 | MP0002063_abnormal_learning/memory/cond | 0.78496423 |
| 140 | MP0000013_abnormal_adipose_tissue | 0.77584924 |
| 141 | MP0004087_abnormal_muscle_fiber | 0.77041969 |
| 142 | MP0002269_muscular_atrophy | 0.75831735 |
| 143 | MP0003283_abnormal_digestive_organ | 0.74882840 |
| 144 | MP0002928_abnormal_bile_duct | 0.74291734 |
| 145 | MP0001730_embryonic_growth_arrest | 0.73612807 |
| 146 | MP0003123_paternal_imprinting | 0.72630910 |
| 147 | MP0005334_abnormal_fat_pad | 0.72147319 |
| 148 | MP0001348_abnormal_lacrimal_gland | 0.71748444 |
| 149 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71501677 |
| 150 | MP0005670_abnormal_white_adipose | 0.69806841 |
| 151 | MP0008770_decreased_survivor_rate | 0.68612394 |
| 152 | MP0003091_abnormal_cell_migration | 0.68408154 |
| 153 | MP0002089_abnormal_postnatal_growth/wei | 0.66784802 |
| 154 | MP0004858_abnormal_nervous_system | 0.65504267 |
| 155 | MP0000733_abnormal_muscle_development | 0.65464286 |
| 156 | MP0009643_abnormal_urine_homeostasis | 0.64408481 |
| 157 | MP0004808_abnormal_hematopoietic_stem | 0.64030337 |
| 158 | MP0002896_abnormal_bone_mineralization | 0.62986840 |
| 159 | MP0010630_abnormal_cardiac_muscle | 0.62899325 |
| 160 | MP0006036_abnormal_mitochondrial_physio | 0.62738007 |
| 161 | MP0002970_abnormal_white_adipose | 0.62439187 |
| 162 | MP0005330_cardiomyopathy | 0.61191437 |
| 163 | MP0002086_abnormal_extraembryonic_tissu | 0.60530201 |
| 164 | MP0004811_abnormal_neuron_physiology | 0.60410532 |
| 165 | MP0005464_abnormal_platelet_physiology | 0.60051230 |
| 166 | MP0003115_abnormal_respiratory_system | 0.59131018 |
| 167 | MP0004197_abnormal_fetal_growth/weight/ | 0.58979015 |
| 168 | MP0009642_abnormal_blood_homeostasis | 0.57945836 |
| 169 | MP0005448_abnormal_energy_balance | 0.57634736 |
| 170 | MP0003633_abnormal_nervous_system | 0.57410437 |
| 171 | MP0005023_abnormal_wound_healing | 0.56955393 |
| 172 | MP0009763_increased_sensitivity_to | 0.54834194 |
| 173 | MP0005266_abnormal_metabolism | 0.54344379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.97807054 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 4.02262456 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.51129796 |
| 4 | Xanthomatosis (HP:0000991) | 3.47777131 |
| 5 | Abnormality of the Achilles tendon (HP:0005109) | 3.25214670 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.23925922 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.16596918 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 3.12544960 |
| 9 | Ketosis (HP:0001946) | 3.01453732 |
| 10 | Flat acetabular roof (HP:0003180) | 2.99413895 |
| 11 | Achilles tendon contracture (HP:0001771) | 2.98181229 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 2.97446636 |
| 13 | Thin bony cortex (HP:0002753) | 2.88791541 |
| 14 | Protrusio acetabuli (HP:0003179) | 2.80367866 |
| 15 | Reticulocytosis (HP:0001923) | 2.79786946 |
| 16 | Spastic diplegia (HP:0001264) | 2.76156754 |
| 17 | Hyperammonemia (HP:0001987) | 2.72650505 |
| 18 | Eczematoid dermatitis (HP:0000976) | 2.72260493 |
| 19 | Dysmetric saccades (HP:0000641) | 2.65614227 |
| 20 | Lymphangioma (HP:0100764) | 2.61805000 |
| 21 | Obstructive sleep apnea (HP:0002870) | 2.60516725 |
| 22 | Hypoglycemic coma (HP:0001325) | 2.57939822 |
| 23 | Upper limb amyotrophy (HP:0009129) | 2.56234350 |
| 24 | Distal upper limb amyotrophy (HP:0007149) | 2.56234350 |
| 25 | Ketoacidosis (HP:0001993) | 2.54969554 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 2.54275246 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 2.50203781 |
| 28 | Cholelithiasis (HP:0001081) | 2.49585239 |
| 29 | Hypolipoproteinemia (HP:0010981) | 2.47022854 |
| 30 | Enlarged penis (HP:0000040) | 2.44539703 |
| 31 | Epidermoid cyst (HP:0200040) | 2.44487483 |
| 32 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.44243600 |
| 33 | Poikilocytosis (HP:0004447) | 2.39318106 |
| 34 | Complement deficiency (HP:0004431) | 2.38826894 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 2.36454086 |
| 36 | Increased IgE level (HP:0003212) | 2.34452542 |
| 37 | Insomnia (HP:0100785) | 2.34232957 |
| 38 | Vertebral compression fractures (HP:0002953) | 2.34151832 |
| 39 | Asymmetry of the thorax (HP:0001555) | 2.32936785 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29072012 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29072012 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29072012 |
| 43 | Broad face (HP:0000283) | 2.29047897 |
| 44 | Acanthocytosis (HP:0001927) | 2.27351572 |
| 45 | Macroorchidism (HP:0000053) | 2.26535938 |
| 46 | Hand muscle atrophy (HP:0009130) | 2.25344397 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 2.24412404 |
| 48 | Cholecystitis (HP:0001082) | 2.24412404 |
| 49 | Global brain atrophy (HP:0002283) | 2.24249386 |
| 50 | Abnormal gallbladder morphology (HP:0012437) | 2.23125839 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 2.22325700 |
| 52 | Premature rupture of membranes (HP:0001788) | 2.22060403 |
| 53 | Turricephaly (HP:0000262) | 2.22030600 |
| 54 | Spondylolisthesis (HP:0003302) | 2.20990013 |
| 55 | Arterial tortuosity (HP:0005116) | 2.18653281 |
| 56 | Spinal cord lesions (HP:0100561) | 2.18361005 |
| 57 | Syringomyelia (HP:0003396) | 2.18361005 |
| 58 | Hepatocellular carcinoma (HP:0001402) | 2.18230349 |
| 59 | Skin nodule (HP:0200036) | 2.17526713 |
| 60 | Mitral valve prolapse (HP:0001634) | 2.16861516 |
| 61 | Dysostosis multiplex (HP:0000943) | 2.15158979 |
| 62 | Cutaneous melanoma (HP:0012056) | 2.14494256 |
| 63 | Abnormal social behavior (HP:0012433) | 2.11633962 |
| 64 | Impaired social interactions (HP:0000735) | 2.11633962 |
| 65 | Hyperacusis (HP:0010780) | 2.11516947 |
| 66 | Dilatation of the ascending aorta (HP:0005111) | 2.11513298 |
| 67 | Vascular tortuosity (HP:0004948) | 2.11356839 |
| 68 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10083450 |
| 69 | Heterotopia (HP:0002282) | 2.09902951 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.09584443 |
| 71 | Fatigue (HP:0012378) | 2.09521034 |
| 72 | Polycythemia (HP:0001901) | 2.08743039 |
| 73 | Myokymia (HP:0002411) | 2.07382689 |
| 74 | Atrioventricular block (HP:0001678) | 2.05823469 |
| 75 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.04792809 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.04268287 |
| 77 | Abnormality of oral frenula (HP:0000190) | 2.04099975 |
| 78 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03523047 |
| 79 | Cellulitis (HP:0100658) | 2.02574500 |
| 80 | Gingivitis (HP:0000230) | 2.01899422 |
| 81 | Myocardial infarction (HP:0001658) | 2.01316858 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.01070397 |
| 83 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.00551216 |
| 84 | Genu recurvatum (HP:0002816) | 1.99543265 |
| 85 | Neurofibrillary tangles (HP:0002185) | 1.98962012 |
| 86 | Buphthalmos (HP:0000557) | 1.98552352 |
| 87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97340266 |
| 88 | Osteolytic defects of the hand bones (HP:0009699) | 1.97340266 |
| 89 | Neonatal onset (HP:0003623) | 1.96933439 |
| 90 | Aneurysm (HP:0002617) | 1.94807865 |
| 91 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.93660293 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 1.93588033 |
| 93 | Recurrent abscess formation (HP:0002722) | 1.92645367 |
| 94 | Hamartoma of the eye (HP:0010568) | 1.92425798 |
| 95 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.92040749 |
| 96 | Disproportionate tall stature (HP:0001519) | 1.91510704 |
| 97 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91310202 |
| 98 | Resting tremor (HP:0002322) | 1.91207951 |
| 99 | Hyperparathyroidism (HP:0000843) | 1.91015143 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.91004165 |
| 101 | Pustule (HP:0200039) | 1.90882404 |
| 102 | Myoglobinuria (HP:0002913) | 1.90370926 |
| 103 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89145664 |
| 104 | Difficulty climbing stairs (HP:0003551) | 1.88979586 |
| 105 | Poor eye contact (HP:0000817) | 1.88784582 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 1.88018093 |
| 107 | Abnormality of carpal bone ossification (HP:0006257) | 1.87688890 |
| 108 | Bundle branch block (HP:0011710) | 1.87568234 |
| 109 | Sensorimotor neuropathy (HP:0007141) | 1.87044078 |
| 110 | Abnormal cartilage morphology (HP:0002763) | 1.86710098 |
| 111 | Long toe (HP:0010511) | 1.86630757 |
| 112 | Autoimmune thrombocytopenia (HP:0001973) | 1.86232956 |
| 113 | Atrophic scars (HP:0001075) | 1.85926461 |
| 114 | Prolonged partial thromboplastin time (HP:0003645) | 1.85497239 |
| 115 | Spinal cord compression (HP:0002176) | 1.84979962 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 1.84696213 |
| 117 | Spontaneous hematomas (HP:0007420) | 1.84694595 |
| 118 | Wormian bones (HP:0002645) | 1.84603269 |
| 119 | Status epilepticus (HP:0002133) | 1.84507029 |
| 120 | Renovascular hypertension (HP:0100817) | 1.84447688 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.83773786 |
| 122 | Spontaneous abortion (HP:0005268) | 1.83696873 |
| 123 | Gout (HP:0001997) | 1.83601698 |
| 124 | Angiofibromas (HP:0010615) | 1.83130528 |
| 125 | Adenoma sebaceum (HP:0009720) | 1.83130528 |
| 126 | Hemorrhage of the eye (HP:0011885) | 1.82851924 |
| 127 | Abnormal ossification of hand bones (HP:0005921) | 1.82101836 |
| 128 | Malnutrition (HP:0004395) | 1.81915454 |
| 129 | Papilledema (HP:0001085) | 1.81857494 |
| 130 | Polygenic inheritance (HP:0010982) | 1.81451229 |
| 131 | Coarse hair (HP:0002208) | 1.80647557 |
| 132 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.80510767 |
| 133 | Mucopolysacchariduria (HP:0008155) | 1.80510767 |
| 134 | Aortic aneurysm (HP:0004942) | 1.80396927 |
| 135 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79864765 |
| 136 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79864765 |
| 137 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79864765 |
| 138 | Visual hallucinations (HP:0002367) | 1.79679553 |
| 139 | Fibroma (HP:0010614) | 1.79529842 |
| 140 | Onion bulb formation (HP:0003383) | 1.78800962 |
| 141 | Thick nail (HP:0001805) | 1.78788168 |
| 142 | Slow saccadic eye movements (HP:0000514) | 1.78620659 |
| 143 | Cervical subluxation (HP:0003308) | 1.78417017 |
| 144 | Hypercholesterolemia (HP:0003124) | 1.78057586 |
| 145 | Ankyloglossia (HP:0010296) | 1.78016107 |
| 146 | Fragile skin (HP:0001030) | 1.77588287 |
| 147 | Distal lower limb muscle weakness (HP:0009053) | 1.77337707 |
| 148 | Autoimmune hemolytic anemia (HP:0001890) | 1.77224978 |
| 149 | Increased cerebral lipofuscin (HP:0011813) | 1.75965729 |
| 150 | Loss of speech (HP:0002371) | 1.75906090 |
| 151 | Emphysema (HP:0002097) | 1.75798958 |
| 152 | Coxa vara (HP:0002812) | 1.75736362 |
| 153 | Mitral stenosis (HP:0001718) | 1.75510438 |
| 154 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75190676 |
| 155 | Abnormality of complement system (HP:0005339) | 1.74779139 |
| 156 | Striae distensae (HP:0001065) | 1.74395189 |
| 157 | Ulnar bowing (HP:0003031) | 1.73688830 |
| 158 | Urinary urgency (HP:0000012) | 1.71879754 |
| 159 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.71413083 |
| 160 | Abnormality of glycine metabolism (HP:0010895) | 1.71413083 |
| 161 | Insidious onset (HP:0003587) | 1.71003898 |
| 162 | Termporal pattern (HP:0011008) | 1.71003898 |
| 163 | Periodontitis (HP:0000704) | 1.70441752 |
| 164 | Abnormality of the fingertips (HP:0001211) | 1.70272771 |
| 165 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70194662 |
| 166 | Bone pain (HP:0002653) | 1.70111943 |
| 167 | Hyperglycinemia (HP:0002154) | 1.69626841 |
| 168 | Pointed chin (HP:0000307) | 1.69282724 |
| 169 | Recurrent viral infections (HP:0004429) | 1.68074115 |
| 170 | Cupped ribs (HP:0000887) | 1.66055318 |
| 171 | Aortic dissection (HP:0002647) | 1.63739138 |
| 172 | Milia (HP:0001056) | 1.63575788 |
| 173 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.63243289 |
| 174 | Dislocated radial head (HP:0003083) | 1.62189787 |
| 175 | Vasculitis (HP:0002633) | 1.62135707 |
| 176 | Blue sclerae (HP:0000592) | 1.61717133 |
| 177 | Persistence of primary teeth (HP:0006335) | 1.59036377 |
| 178 | Myositis (HP:0100614) | 1.58364169 |
| 179 | Short nail (HP:0001799) | 1.57532168 |
| 180 | Orchitis (HP:0100796) | 1.56489639 |
| 181 | Mitral regurgitation (HP:0001653) | 1.55705194 |
| 182 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.52807148 |
| 183 | Gastrointestinal infarctions (HP:0005244) | 1.52529642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRD4 | 5.84689925 |
| 2 | TRIB3 | 4.93850737 |
| 3 | PRPF4B | 4.54037772 |
| 4 | PKN2 | 3.93308874 |
| 5 | IRAK3 | 3.37820359 |
| 6 | EEF2K | 2.59872459 |
| 7 | MAP3K13 | 2.48985592 |
| 8 | KSR2 | 2.38586405 |
| 9 | RIPK1 | 2.26383107 |
| 10 | MAP3K14 | 2.22986557 |
| 11 | PRKD3 | 1.98021074 |
| 12 | DAPK2 | 1.91570646 |
| 13 | MAP4K1 | 1.88796823 |
| 14 | SCYL2 | 1.88472172 |
| 15 | SMG1 | 1.86806506 |
| 16 | MAP3K9 | 1.80956551 |
| 17 | MST1R | 1.77272213 |
| 18 | TAOK1 | 1.66863766 |
| 19 | NEK9 | 1.64079766 |
| 20 | CAMKK1 | 1.63111847 |
| 21 | MAP3K10 | 1.58869751 |
| 22 | ZAP70 | 1.57977292 |
| 23 | MAP3K2 | 1.57735455 |
| 24 | ERN1 | 1.55664742 |
| 25 | FRK | 1.54882125 |
| 26 | RET | 1.52031216 |
| 27 | ALK | 1.51091700 |
| 28 | LATS2 | 1.50864314 |
| 29 | MAP3K7 | 1.49107625 |
| 30 | TAOK2 | 1.45464169 |
| 31 | MAP3K3 | 1.45462908 |
| 32 | EPHA2 | 1.45102297 |
| 33 | IRAK2 | 1.41791757 |
| 34 | EPHB1 | 1.41237229 |
| 35 | MAP2K4 | 1.41232146 |
| 36 | PAK6 | 1.41229336 |
| 37 | MAP3K4 | 1.38424214 |
| 38 | TBK1 | 1.37100157 |
| 39 | IRAK1 | 1.36874166 |
| 40 | SIK3 | 1.36573615 |
| 41 | EPHA4 | 1.36215353 |
| 42 | LATS1 | 1.33981530 |
| 43 | NEK1 | 1.33026751 |
| 44 | NTRK3 | 1.32971567 |
| 45 | PTK6 | 1.32910217 |
| 46 | PDGFRA | 1.32104944 |
| 47 | IRAK4 | 1.30991684 |
| 48 | RIPK4 | 1.30189095 |
| 49 | TYK2 | 1.28632193 |
| 50 | SIK1 | 1.27721037 |
| 51 | TTN | 1.25026186 |
| 52 | FLT3 | 1.11805862 |
| 53 | BMPR2 | 1.08175383 |
| 54 | CDK9 | 1.03738625 |
| 55 | BMX | 1.00566878 |
| 56 | JAK1 | 1.00456514 |
| 57 | CDK12 | 0.91572888 |
| 58 | CSK | 0.90884901 |
| 59 | EPHA3 | 0.90504304 |
| 60 | IKBKB | 0.90388020 |
| 61 | PTK2B | 0.90100343 |
| 62 | KSR1 | 0.88013930 |
| 63 | STK38 | 0.86336450 |
| 64 | BCKDK | 0.86282475 |
| 65 | PDK3 | 0.86083352 |
| 66 | PDK4 | 0.86083352 |
| 67 | FES | 0.85212660 |
| 68 | TGFBR2 | 0.85186655 |
| 69 | IKBKE | 0.85056796 |
| 70 | CDC7 | 0.81225610 |
| 71 | CDC42BPA | 0.80523700 |
| 72 | SGK3 | 0.79854051 |
| 73 | MAP3K1 | 0.79540122 |
| 74 | FGFR2 | 0.79147182 |
| 75 | NTRK1 | 0.78337941 |
| 76 | STK24 | 0.77851152 |
| 77 | MINK1 | 0.77695222 |
| 78 | TAOK3 | 0.76573515 |
| 79 | NME2 | 0.75050556 |
| 80 | FGFR4 | 0.74709827 |
| 81 | PRKD2 | 0.74322878 |
| 82 | MAP2K3 | 0.71901282 |
| 83 | MAPK7 | 0.71558914 |
| 84 | HCK | 0.70820751 |
| 85 | FGFR3 | 0.70778839 |
| 86 | MTOR | 0.70680406 |
| 87 | RPS6KL1 | 0.70433362 |
| 88 | RPS6KC1 | 0.70433362 |
| 89 | DAPK1 | 0.69139823 |
| 90 | TYRO3 | 0.69075676 |
| 91 | PAK4 | 0.68011704 |
| 92 | CHUK | 0.66571529 |
| 93 | PRKCH | 0.66537186 |
| 94 | CDK6 | 0.64864762 |
| 95 | PDK1 | 0.63797875 |
| 96 | JAK2 | 0.63421354 |
| 97 | MAP3K11 | 0.61727799 |
| 98 | MAP2K1 | 0.61497908 |
| 99 | DDR2 | 0.61148827 |
| 100 | CAMK1D | 0.60865379 |
| 101 | MET | 0.60544480 |
| 102 | NEK2 | 0.59644009 |
| 103 | MAP3K6 | 0.59578506 |
| 104 | MAPK11 | 0.58929559 |
| 105 | PAK2 | 0.58920812 |
| 106 | STK11 | 0.58800605 |
| 107 | LMTK2 | 0.58300534 |
| 108 | LRRK2 | 0.57961596 |
| 109 | PDPK1 | 0.57687785 |
| 110 | TRPM7 | 0.57011732 |
| 111 | TXK | 0.55575935 |
| 112 | CDK4 | 0.52437397 |
| 113 | SIK2 | 0.52169671 |
| 114 | RPS6KA6 | 0.51233515 |
| 115 | MAPK12 | 0.50353158 |
| 116 | RAF1 | 0.49856889 |
| 117 | BLK | 0.49661375 |
| 118 | CAMK1G | 0.49557593 |
| 119 | STK10 | 0.49239178 |
| 120 | TIE1 | 0.47396905 |
| 121 | MAPK4 | 0.46840498 |
| 122 | CDK5 | 0.46549643 |
| 123 | PTK2 | 0.45335747 |
| 124 | CLK1 | 0.44757565 |
| 125 | MAP3K8 | 0.43881924 |
| 126 | PRKCZ | 0.42382892 |
| 127 | CAMK4 | 0.40912443 |
| 128 | MOS | 0.39697309 |
| 129 | GRK6 | 0.39615109 |
| 130 | RPS6KB1 | 0.38649723 |
| 131 | ICK | 0.38335801 |
| 132 | ILK | 0.38210751 |
| 133 | STK3 | 0.37878433 |
| 134 | PDGFRB | 0.37026259 |
| 135 | RPS6KA4 | 0.34659365 |
| 136 | RPS6KA3 | 0.31212396 |
| 137 | HIPK2 | 0.30309339 |
| 138 | JAK3 | 0.30097039 |
| 139 | MARK2 | 0.29708144 |
| 140 | PRKAA2 | 0.29427542 |
| 141 | MAP3K5 | 0.28813759 |
| 142 | SGK1 | 0.28640022 |
| 143 | MELK | 0.28274774 |
| 144 | MAPK10 | 0.27735391 |
| 145 | RPS6KA2 | 0.25720958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.29562144 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.04822177 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.85379888 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.89561898 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68669684 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.27973633 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07515992 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.00306063 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.90939777 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89067627 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88681664 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80900177 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.80019324 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79163906 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75279132 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.68386058 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61782982 |
| 18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61025942 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.59717781 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.59496740 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58202020 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.56887666 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55929735 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.53793725 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52737391 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49099070 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45989947 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43220021 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.42532963 |
| 30 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41626703 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38957905 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.38671218 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37757919 |
| 34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37056045 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.36231575 |
| 36 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.36190996 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.31154944 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.31037628 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30484966 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29015839 |
| 41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.29009409 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28837717 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.26878545 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.26739436 |
| 45 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25508364 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 1.25410356 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24743714 |
| 48 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.24589673 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.24001963 |
| 50 | Malaria_Homo sapiens_hsa05144 | 1.19757135 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18409227 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.16796481 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 1.16676985 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.16167859 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 1.15947071 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15486878 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14883451 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.14518780 |
| 59 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12775207 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 1.11571044 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11530401 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 1.11163263 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10242752 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 1.10092281 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09295878 |
| 66 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08776367 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05806320 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04086624 |
| 69 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01729333 |
| 70 | Shigellosis_Homo sapiens_hsa05131 | 1.00799370 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.00459031 |
| 72 | Prostate cancer_Homo sapiens_hsa05215 | 1.00430990 |
| 73 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00218637 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 1.00172439 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99616035 |
| 76 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98715375 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.96320675 |
| 78 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95580764 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95227814 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.95063455 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.94338800 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93699281 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.93318487 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.91903681 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90580599 |
| 86 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90124626 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89095775 |
| 88 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89059309 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88562756 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88296807 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88261694 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87479066 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86981199 |
| 94 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85829687 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.85787844 |
| 96 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.85459271 |
| 97 | Focal adhesion_Homo sapiens_hsa04510 | 0.85160466 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84951296 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84445493 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.83876674 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.83372820 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.82233634 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.81685260 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81493360 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81219049 |
| 106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80251340 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.80140864 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78142902 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77709070 |
| 110 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.77606166 |
| 111 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77603679 |
| 112 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77519255 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76943755 |
| 114 | Platelet activation_Homo sapiens_hsa04611 | 0.76485194 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75630623 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75009651 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73144081 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.72034279 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71867762 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.71785726 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.70244655 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70033462 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66527934 |
| 124 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65366663 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.65055509 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64479198 |
| 127 | Endocytosis_Homo sapiens_hsa04144 | 0.63705810 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62934511 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62910589 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62868382 |
| 131 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61312519 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61257933 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.60598950 |
| 134 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59915137 |
| 135 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59901893 |
| 136 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56545933 |
| 137 | Insulin secretion_Homo sapiens_hsa04911 | 0.54593042 |
| 138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54271771 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53233483 |
| 140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53012680 |
| 141 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52903813 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52877854 |
| 143 | ABC transporters_Homo sapiens_hsa02010 | 0.52551765 |
| 144 | Adherens junction_Homo sapiens_hsa04520 | 0.52448838 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51185957 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51139600 |
| 147 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50930737 |
| 148 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49699332 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49607077 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47190733 |
| 151 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46884651 |
| 152 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.46475190 |
| 153 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45925724 |
| 154 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.45893688 |
| 155 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45522187 |
| 156 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43657394 |
| 157 | Salivary secretion_Homo sapiens_hsa04970 | 0.42651260 |
| 158 | Renin secretion_Homo sapiens_hsa04924 | 0.41371182 |
| 159 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40356013 |
| 160 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40241310 |
| 161 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39826463 |
| 162 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39408271 |
| 163 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39066178 |
| 164 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37786242 |
| 165 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35515141 |
| 166 | Prion diseases_Homo sapiens_hsa05020 | 0.35278607 |
| 167 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34372153 |
| 168 | Gap junction_Homo sapiens_hsa04540 | 0.34109699 |
| 169 | GABAergic synapse_Homo sapiens_hsa04727 | 0.32346347 |
| 170 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32042559 |

